Other sickle-cell disorders with cerebral vascular involvement
ICD-10 D57.813 is a billable code used to indicate a diagnosis of other sickle-cell disorders with cerebral vascular involvement.
D57.813 refers to a subset of sickle-cell disorders characterized by the presence of cerebral vascular involvement, which can lead to complications such as stroke or transient ischemic attacks. Sickle-cell disease (SCD) is a genetic blood disorder caused by a mutation in the hemoglobin gene, leading to the production of abnormal hemoglobin S. This abnormality causes red blood cells to become rigid and sickle-shaped, resulting in hemolytic anemia, vaso-occlusive crises, and increased risk of infections. In patients with cerebral vascular involvement, the sickled cells can obstruct blood flow to the brain, leading to ischemic damage. This condition is often exacerbated by factors such as dehydration, infection, and high altitudes. Management typically includes hydration, pain control, and blood transfusions, along with preventive measures such as hydroxyurea therapy to reduce the frequency of sickle cell crises. Understanding the genetic basis of sickle-cell disorders and their complications is crucial for effective treatment and management.
Detailed history of sickle-cell disease, including previous crises and treatments.
Management of acute sickle cell crises, stroke prevention, and blood transfusion therapy.
Ensure documentation reflects the severity of the disease and any neurological complications.
Neurological assessments, imaging studies, and detailed descriptions of any cerebrovascular events.
Evaluation and management of stroke or transient ischemic attacks in patients with sickle-cell disease.
Document the relationship between sickle-cell disease and neurological symptoms clearly.
Used in the management of sickle-cell crises and prevention of stroke.
Document the indication for transfusion and the patient's response.
Hematology specialists should ensure that transfusion protocols are followed.
Coding D57.813 accurately reflects the presence of cerebral vascular involvement in sickle-cell disorders, which is critical for appropriate management and treatment planning.
